Home
NewsNewsFertility is a person’s ability to conceive children. In general, when a woman is unable to get pregnant even after at least one year of unprotected sex, she is considered to have infertility and her doctor will begin evaluating the possible causes.
Fertility is a person’s ability to conceive children. In general, when a woman is unable to get pregnant even after at least one year of unprotected sex, she is considered to have infertility and her doctor will begin evaluating the possible causes. Of course, infertility is not strictly a female problem. According to the Centers for Disease Control and Prevention, in 35 percent of couples who cannot conceive, the cause can be attributed to factors on both the female and male side. And in 8 percent of couples, the only cause that can be found is a male factor.
Infertility has several possible causes. In women, problems with ovarian function, obstructed fallopian tubes, or uterine abnormalities like fibroids are common causes. In men, infertility can be the result of disrupted testicular or ejaculatory function, or a hormonal or genetic condition.
In both men and women, factors that can contribute to infertility include age, smoking, alcohol and drug use, certain medications, cancer treatments, and certain medical conditions.
Women or men who are having trouble conceiving should ask their doctor for a referral to a reproductive endocrinologist, who can help identify the possible causes, recommend treatments, and discuss options including artificial insemination and assisted reproductive technology.
For the first time, the World Health Organization has officially listed the Ministry of Health, Labor, and Welfare/Pharmaceuticals and Medical Devices Agency (MHLW/PMDA) of Japan, Health Canada, and the Medicines and Healthcare Products Regulatory Agency (MHRA) of the UK as the new WHO-listed authorities (WLAs), a status that is granted to national authorities that meet the highest international regulatory benchmarks when it comes to medical products.
Menopause can usher in a host of disruptive symptoms like hot flashes, night sweats and sleep problems. Hormone therapy promises relief. But many women wonder about taking it. That’s because the treatment, subject of a recent expert panel convened by the Food and Drug Administration, has long been shrouded in uncertainty.
With the partnership, PatientPoint’s waiting room and exam room screens will feature messaging that promotes MyHealthTeam’s platform, which serves over 27 million patients annually through an expanding network of more than 60 patient communities
In an age where customization is prized as well as friction is the enemy of efficiency, zero-click care – passive patient engagement by way of ambient sensing and IoT in hospitals
Explore the cost of IUI worldwide, comparing prices and factors aExplore the cost of IUI worldwide, comparing prices and factors aExplore the cost of IUI worldwide, comparing prices and factors a
Under the terms of the agreement, Exeltis will acquire exclusive rights to market and distribute Theranexus’ proprietary product across key regions, including the European Union, UK, Latin America, and selected Middle Eastern countries. This collaboration will target both Gaucher and Niemann-Pick type C diseases.
